Trial NCT04323436

View at ClinicalTrials.gov 
Org. Study IDs: CINC280J12201
Secondary IDs: 2019-003097-11

Last trial update was posted on 2024-02-06

MeSH Interventions

Spartalizumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions


Stopping Reasons

Study termination based on sponsor decision due to lack of tolerability observed with capmatinib and spartalizumab combination treatment when compared to data from capmatinib single agent studies

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID